Radius Health Inc.

NASDAQ:RDUS   3:59:43 PM EDT
13.88
+0.10 (+0.73%)
Products, Regulatory

Radius Health & Menarini Group Provide Elacestrant Update

Published: 09/25/2020 10:08 GMT
Radius Health Inc (RDUS) - Radius Health & Menarini Group Provide Elacestrant Update.
Radius Health Inc - Target Enrollment Milestone Reached in Phase 3 Emerald Study.
Radius Health Inc - Life Cycle Planning Advancing in Parallel With Current Phase 3 Monotherapy Program.
Radius Health Inc - Idmc Recommended That Trial Continues to Advance in an Unmodified Manner.
Radius Health Inc - Analysis of Primary Endpoint of Study is Anticipated Will Take Place in Second Half of 2021.